Scientific Advisory Council Meeting: Accelerate Genomic Research
The TB Alliance Scientific Advisory Committee (SAC) reviewed progress and outlined future research directions for the ongoing R&D strategy of
The TB Alliance Scientific Advisory Committee (SAC) reviewed progress and outlined future research directions for the ongoing R&D strategy of
The International Union Against Tuberculosis and Lung Disease (IUATLD), one of the TB Alliance Stakeholders, hosted its annual World Conference
The Global Alliance for TB Drug Development (TB Alliance) is holding its Stakeholders Association Meeting on October 7, 2002 in
The Commission on Intellectual Property Rights, published its final report: “Integrating Intellectual Property Rights and Development Policy.” The report recommends
HIV-AIDS and TB Epidemics Fueling Each Other in Deadly Spin One in three HIV-infected people worldwide is coinfected with the
European Union Trade Commissioner, Pascal Lamy, issued his latest thoughts on the discussion on medicines and intellectual property, highlighting the
The 4th World TB Congress took place in Washington, D.C. (June 3-5, 2002). The TB Alliance was one of the